has been cited by the following article(s):
|
[1]
|
Analytical Methodologies for Anti-Infective Orphan Drugs: A Comprehensive Review of FDA Approvals (2013-2023) Part 1
Critical Reviews in Analytical Chemistry,
2025
DOI:10.1080/10408347.2025.2459721
|
|
|
|
|
[2]
|
AQbD-guided development and validation of an innovative extraction procedure and stability-indicating RP-HPLC method for quantification of posaconazole in tablet formulation
Annales Pharmaceutiques Françaises,
2024
DOI:10.1016/j.pharma.2024.07.003
|
|
|
|
|
[3]
|
Advancing posaconazole quantification analysis with a new reverse-phase HPLC method in its bulk and marketed dosage form
F1000Research,
2023
DOI:10.12688/f1000research.132841.2
|
|
|
|
|
[4]
|
Advancing posaconazole quantification analysis with a new reverse-phase HPLC method in its bulk and marketed dosage form
F1000Research,
2023
DOI:10.12688/f1000research.132841.1
|
|
|
|
|
[5]
|
Development and Validation of a LC–MS/MS Method for the Profiling of Impurities Formed during Stress Study of Antifungal Agent—Efinaconazole
Journal of Chromatographic Science,
2022
DOI:10.1093/chromsci/bmab079
|
|
|
|
|
[6]
|
Identification, synthesis, characterization, and a quality control strategy for high-risk chiral impurities in the antifungal drug substance posaconazole
Tetrahedron,
2022
DOI:10.1016/j.tet.2022.133098
|
|
|
|
|
[7]
|
Identification, synthesis, characterization, and a quality control strategy for high-risk chiral impurities in the antifungal drug substance posaconazole
Tetrahedron,
2022
DOI:10.1016/j.tet.2022.133098
|
|
|
|
|
[8]
|
Stability study and oxidative degradation kinetics of posaconazole
Microchemical Journal,
2019
DOI:10.1016/j.microc.2019.104181
|
|
|
|